Last quarter (Q2 2023), Baudax Bio's total revenue was $30.00K, a decrease of -90.00% from the same quarter last year. In Q2, Baudax Bio's net income was $-7.30M. See Baudax Bio’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 591.00K	$ 1.27M	$ 1.08M	$ 493.00K	$ 0.00	$ 0.00
Cost of Revenue	$ -3.88M	$ -7.01M	-	$ 1.73M	$ 0.00	-
Gross Profit	$ -5.60M	$ -9.90M	$ 1.08M	$ -1.24M	$ 0.00	-
Operating Expense	$ 17.01M	$ 30.00M	$ 53.46M	$ 54.57M	$ 47.07M	$ 65.04M
Operating Income	$ -25.97M	$ -39.90M	$ -52.38M	$ -55.81M	$ -47.07M	$ -65.04M
Net Non Operating Interest Income Expense	$ -3.35M	$ -1.98M	$ -2.30M	$ -1.36M	$ 0.00	-
Other Income Expense	$ -21.16M	$ -2.77M	$ -32.61M	$ -18.93M	$ 14.52M	$ -8.63M
Pretax Income	$ -53.14M	$ -58.80M	$ -19.77M	$ -76.10M	$ -32.56M	$ -73.67M
Tax Provision	-	-	$ 0.00	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -53.14M	$ -58.80M	$ -19.77M	$ -76.10M	$ -32.56M	$ -73.67M
Basic EPS	$ -270.69	$ -177.30	$ -405.60	$ -137.55	$ -3.48	$ -8.11
Diluted EPS	$ -267.52	$ -177.30	$ -405.60	$ -137.55	$ -3.48	$ -8.11
Basic Average Shares	$ 7.83M	$ 331.62K	$ 54.74K	$ 553.02K	$ 9.35M	$ 9.08M
Diluted Average Shares	$ 7.83M	$ 331.62K	$ 54.74K	$ 553.02K	$ 9.35M	$ 9.08M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 13.13M	$ 22.99M	$ 53.46M	$ 56.30M	$ 47.07M	$ 65.04M
Net Income From Continuing And Discontinued Operation	$ -34.43M	$ -58.80M	$ -19.77M	$ -76.10M	$ -32.56M	$ -73.67M
Normalized Income	$ -11.63M	-	-	$ -57.12M	$ -47.11M	$ -65.17M
Interest Expense	-	-	-	$ 1.36M	$ 0.00	-
EBIT	$ -29.35M	$ -58.80M	$ -19.77M	$ -74.74M	$ -32.56M	$ -65.04M
EBITDA	$ -28.60M	$ -56.63M	$ -16.95M	$ -72.19M	$ -32.08M	$ -64.64M

Currency in USD

Baudax Bio Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing